BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk

  reMYND’s pre-clinical diabetes therapy ReS39 will get a significant boost after the company entered a licensing agreement with noted European diabetes company Novo Nordisk.

  December 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies

  Investors were Atlas Venture and OrbiMed.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  GRAIL Poaches New CEO From Roche, Genentech

  Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement.

  December 14, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Sanofi Genzyme Recalls Contaminated Arthritis Gel

  A lot containing 18,000 gel-filled syringes of Sinvisc-One tested positive for microbial contamination.

  December 14, 2017

   · 

  1 min read
• 

  Business

  These 2 Startups are Amgen’s 2017 Golden Ticket Winners

  Amgen tapped two companies to receive its coveted 2017 Golden Ticket at LabCentral.

  December 14, 2017

   · 

  3 min read

   · 

  Alex Keown
• FDA

  Karolinska Development’s Portfolio Company Promimic Receives FDA Approval for HAnano Surface for Use on Dental Implants

  The approval of HAnano Surface in the United States has been executed in accordance with the new 510(k) legislation for medical devices.

  December 14, 2017

   · 

  1 min read
• 

  Business

  Asklepios BioPharma Launches New Biotech Actus Therapeutics

  Asklepios BioPharma is forming a new biotech portfolio company, Actus Therapeutics.

  December 14, 2017

   · 

  2 min read

   · 

  Mark Terry
• Vernalis PLC: AGM Statement With Strong Unaudited Cash Position

  Vernalis plc provides an update ahead of its Annual General Meeting being held today at 10.30 am at the offices of Covington & Burling, 265 Strand, London WC2R 1BH.

  December 14, 2017

   · 

  9 min read
• Business

  PathoQuest and Mayo Clinic Enter Into an Agreement to Conduct Study of iDTECT Blood in Patients With Febrile Neutropenia

  PathoQuest announced that it will conduct research with Mayo Clinic to study the company’s proprietary iDTECT Blood test.

  December 14, 2017

   · 

  2 min read
• 

  Business

  Takeda Takes Stake, Inks Deal With Newly Launched Izana Bioscience

  As part of the licence agreement, Takeda has taken a strategic equity stake in Izana.

  December 14, 2017

   · 

  4 min read